APITORIA PHARMA PRIVATE LTD

Overview

APITORIA PHARMA PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 311 active FDA Type II Drug Master Files, covering 6-AMINOPENICILLANIC ACID (6-APA); ABACAVIR SULFATE USP; ABACAVIR SULFATE USP (PROCESS II); ABIRATERONE ACETATE USP; ACETAMINOPHEN USP; ALENDRONATE SODIUM USP (NON-STERILE DRUG SUBSTANCE).

API / Drug Master Files

APITORIA PHARMA PRIVATE LTD holds 311 active (314 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• VALGANCICLOVIR HYDROCHLORIDE USP (PROCESS-II)Active2026-03-30
• EMTRICITABINE USP (PROCESS-IV)Active2026-03-26
• DESVENLAFAXINE SUCCINATE USPActive2026-03-25
• SUVOREXANTActive2026-02-25
• MONTELUKAST SODIUM USP (PROCESS II)Active2026-02-05
• DIVALPROEX SODIUM USP (PROCESS-II)Active2026-01-19
• BUPROPION HYDROCHLORIDE USP (PROCESS-II)Active2026-01-14
• MAVACAMTENActive2025-12-25
• METHOCARBAMOL USPActive2025-11-28
• PITAVASTATIN CALCIUM (PROCESS-II)Active2025-11-26
• VONOPRAZAN FUMARATEActive2025-11-04
• AUROPAP 90F (ACETAMINOPHEN DIRECTLY COMPRESSIBLE GRANULES)Active2025-08-02
• PENICILLIN G BENZATHINE (LECITHIN COATED) STERILEActive2025-06-20
• ENOXAPARIN SODIUM USPActive2025-03-27
• CABOTEGRAVIRActive2025-03-25

Showing 15 of 314 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to APITORIA PHARMA PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.